FDA Approved: GRANISETRON HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for Granisetron hydrochloride (generic antiemetic) under ANDA 078629.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting
• Postoperative Nausea and Vomiting

Drugs mentioned

• Granisetron hydrochloride (granisetron hydrochloride)

Snippet

SUPPL AP for GRANISETRON HYDROCHLORIDE (GRANISETRON HYDROCHLORIDE)